ASN Announces Diabetic Kidney Disease Collaborative to Ensure Patient Benefit, Increased Coordination across Specialties
Diabetic kidney diseases develop in approximately 40% of patients who have type 2 diabetes and are the leading cause of CKD worldwide. The condition also accounts for more than 40% of kidney failure in the United States.
With more than 100 million U.S. adults living with diabetes or prediabetes, according to a recent Centers for Disease Control and Prevention report, new treatments are urgently needed to stem the tide of diabetic kidney diseases.
Fortunately, “the outlook for people diagnosed with type 2 diabetes and CKD today is more hopeful than it has ever been,” says Vlado Perkovic, MBBS, PhD, in
© 2021 American Society of Nephrology | All Rights Reserved
Powered by: PubFactory
Powered by PubFactory